NEPHRONOPHTHISIS 16
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
NEPHRONOPHTHISIS 16
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
[Effect of traditional Chinese medicine and Western medicine research on medical records of traditional Chinese medicine].
|
2379302 |
1990 |
Nephronophthisis
|
0.430 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
NEPHRONOPHTHISIS 16
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3.
|
23793029 |
2013 |
Polycystic Kidney Diseases
|
0.320 |
Biomarker
|
group |
RGD |
Thus, we not only provide the first in vivo evidence for a causal link between the novel Anks6((p.R823W)) gene mutation and polycystic kidney disease, but we also developed a new transgenic rat model that will serve as an important resource for further exploration of the still unknown function of Anks6.
|
21119215 |
2010 |
Polycystic Kidney Diseases
|
0.320 |
Biomarker
|
group |
RGD |
Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/+) rat.
|
16207829 |
2005 |
Nephronophthisis, familial juvenile
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3.
|
23793029 |
2013 |
NEPHRONOPHTHISIS 2
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3.
|
23793029 |
2013 |
Nephronophthisis
|
0.430 |
Biomarker
|
disease |
HPO |
|
|
|
Fibrosis, Liver
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Polycystic Kidney Diseases
|
0.320 |
Biomarker
|
group |
HPO |
|
|
|
Cholestasis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Enlarged kidney
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Renal Insufficiency
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
HETEROTAXY, VISCERAL, 2, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 1, X-LINKED
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Heterotaxy, Visceral, 3, Autosomal
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 4, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Heterotaxy Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 6, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study identifies 112 new loci for body mass index in the Japanese population.
|
28892062 |
2017 |
NEPHRONOPHTHISIS 16
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Fibrosis, Liver
|
0.400 |
Biomarker
|
disease |
CTD_human |
We also identify six families with ANKS6 mutations affected by nephronophthisis, including severe cardiovascular abnormalities, liver fibrosis and situs inversus.
|
23793029 |
2013 |
Cystic kidney
|
0.330 |
Biomarker
|
disease |
CTD_human |
ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3.
|
23793029 |
2013 |